Nue Life Health

Nue Life Health is a digital mental health company headquartered in Miami, Florida, that specializes in at-home ketamine therapy combined with proprietary digital integration programs and personalized health coaching. The company's platform leverages data science to tailor treatment protocols to individual patients and track therapeutic outcomes longitudinally, creating a continuously adaptive care experience. By merging pharmacological intervention with digital behavioral support, Nue Life bridges the gap between clinical treatment and ongoing mental wellness management. Their model is designed to expand access to ketamine-assisted therapy beyond traditional clinical settings, removing geographic and logistical barriers that have historically limited patient reach.

Nue Life Health has secured $23 million in Series A funding, signaling strong investor confidence in its hybrid care model and the broader market opportunity within psychedelic and ketamine-assisted mental health treatment. The company operates at the intersection of telehealth, psychiatry, and emerging psychedelic medicine, positioning itself within one of the fastest-growing segments of digital health. Their longitudinal data collection approach gives them a meaningful advantage in building proprietary outcome datasets, which can inform both clinical efficacy claims and future product development. As regulatory and cultural acceptance of ketamine therapy continues to grow, Nue Life is well positioned to capture a significant share of the expanding at-home mental health treatment market.

Nue Life Health represents an important evolution in the neurotechnology and mental health tech landscape by demonstrating how psychedelic-assisted therapies can be responsibly scaled through digital infrastructure. Their integration of data science with therapeutic care sets a precedent for outcome-driven, personalized mental health treatment that goes beyond symptom management. For the broader neurotech industry, Nue Life illustrates a compelling convergence of neuropharmacology, behavioral health coaching, and digital health platforms. As the field continues to explore the therapeutic potential of psychedelic compounds, companies like Nue Life are establishing the operational and clinical frameworks that will define the next generation of brain-focused mental health care.